CAG
DXCM icon

Crestwood Advisors Group’s DexCom DXCM Stock Holding History

Crestwood Advisors Group’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$286K Sell
4,244
-770
-15% -$51.3K ﹤0.01% 698
2026
Q1 		$315K Buy
+5,014
New +$349K 0.01% 556

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Crestwood Advisors Group's DXCM Position: Q2 2026 in Review

Crestwood Advisors Group reduced its DexCom (DXCM) stake by 15% in Q2 2026, selling an estimated $51.3K and leaving 4,244 shares worth $286K. The position accounts for ﹤0.01% of the portfolio, ranked #698.

Crestwood Advisors Group first reported a position in DXCM in Q1 2026 and has held it in 2 quarters since. The position peaked at $315K in Q1 2026. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Crestwood Advisors Group held 4,244 shares of DexCom worth $286K as of Q2 2026.
  • Crestwood Advisors Group sold 770 DexCom shares in Q2 2026, an estimated $51.3K.
  • DexCom made up ﹤0.01% of Crestwood Advisors Group's portfolio in Q2 2026, its #698 holding.
  • Crestwood Advisors Group first reported a position in DexCom in Q1 2026 and has held it in 2 quarters since.
  • Crestwood Advisors Group's DexCom position peaked at $315K in Q1 2026.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Crestwood Advisors Group's 13F filing for Q2 2026, filed 3 Aug 2026.